Learn more about our upcoming Galas and Signature Events Learn More
Guest blog post by Ian Michael Crumm, Celebrity Esthetician, Podcast Host, Key Opinion Leader, Melanoma Advocate and 2025 #GetNaked Spokesperson: Some moments stick with yo...
Six years ago I noticed a dark line in my finger nail that continued to worsen over the course of the year. After my nail started lifting from the nail bed, I went to see m...
#GivingTuesday is TOMORROW! Join Sheila in Supporting the MRF. #GivingTuesday is in less than 24 hours! Your tax-deductible gift received on #GivingTuesday will help...
Ocular melanoma survivor Anne Marie Montijo reflects on the passing of Dr. Oliver Sacks and her own goal to live each day with a spirit of gratitude.
The results are in and #CUREOM Unite! was a tremendous success! Thank you to everyone who gave so generously to this campaign to further patient-centered ocular melanoma (O...
Today the FDA approved Amgen’s drug, Imlygic (Talimogene Laherparepvec or T-VEC), for the treatment of unresectable Stage IIIB, IIIC or IV metastatic melanoma, bringing a...
Guest blogger Connie Popp shares her experience as an ocular melanoma caregiver, advocate and participant in Miles for Melanoma in support of the CURE OM Unite! campaign. 3 Minute Read
Leanda Cave Partners with the Melanoma Research Foundation to Raise Awareness of the Deadliest Form of Skin Cancer WASHINGTON, D.C.— Four-time Triathlon World ...
Guest blogger Frank Nichols shares his story as an ocular melanoma patient, advocate and participant in Miles for Melanoma NYC.
Hi, I'm Nicole Serraiocco. I'm a wife, a mother of 3 children and an IRONMAN. Completing the 2.4 mile swim, 112 mile bike ride and 26.2 mile marathon was the greate...
The Melanoma Research Foundation Announces 4th Annual Miles for Melanoma 5k Run/Walk on the Universal Studios Backlot Washington, D.C. and Los Angeles, CA, March 23,...
The MRF's Jena Dickman, Miles for Melanoma Event Coordinator, appeared on Good Day Columbus on September 18 to educate viewers about melanoma and share details about th...
Statement from Tim Turnham, Executive Director, Melanoma Research Foundation Today the FDA approved Keytruda (pembrolizumab), a new treatment for advanced melan...
Jul 15, 2025 ET
Jul 22, 2025 ET
